Exact Mass: 439.0897

Exact Mass Matches: 439.0897

Found 125 metabolites which its exact mass value is equals to given mass value 439.0897, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(2R)-2-Hydroxy-2-phenylethyl glucosinolate

{[(e)-(3-hydroxy-3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}propylidene)amino]oxy}sulphonic acid

C15H21NO10S2 (439.0607)


(2S)-2-Hydroxy-2-phenylethyl glucosinolate is found in brassicas. (2S)-2-Hydroxy-2-phenylethyl glucosinolate is a constituent of Barbarea vulgaris (winter cress). Constituent of Barbarea vulgaris (winter cress). (2R)-2-Hydroxy-2-phenylethyl glucosinolate is found in brassicas.

   

Glucolimnanthin

1-S-[2-(3-methoxyphenyl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

C15H21NO10S2 (439.0607)


An aralkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a (2-(3-methoxyphenyl)-N-(sulfooxy)ethanimidoyl group at the anomeric sulfur.

   

Glucoaubrietin

4-Methoxybenzyl glucosinolate

C15H21NO10S2 (439.0607)


   

N-Desmethyl-o-O-sulfate rosiglitazone

{2-[(2-{4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy}ethyl)amino]pyridin-3-yl}oxidanesulfonic acid

C17H17N3O7S2 (439.0508)


N-Desmethyl-o-O-sulfate rosiglitazone is a metabolite of rosiglitazone. Rosiglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approximately $2.5bn in 2006, but declined after reports of adverse effects. (Wikipedia)

   

N-Desmethyl-p-O-sulfate rosiglitazone

{6-[(2-{4-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]phenoxy}ethyl)amino]pyridin-3-yl}oxidanesulfonic acid

C17H17N3O7S2 (439.0508)


N-Desmethyl-p-O-sulfate rosiglitazone is a metabolite of rosiglitazone. Rosiglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approximately $2.5bn in 2006, but declined after reports of adverse effects. (Wikipedia)

   

Convergence

1-{pyrazolo[1,5-a]pyrimidine-3-carbonyl}-4-[4-(trifluoromethyl)benzenesulphonyl]piperazine

C18H16F3N5O3S (439.0926)


   

N-(3-Phenylpropyl)-3,4-dihydroxybenzylidene cyanoacetamide

2,2,4,4-tetracyano-N-{[3,4-dihydroxy-2-(3-phenylpropyl)phenyl]methylidene}-3-oxobutanamide

C24H17N5O4 (439.128)


D000970 - Antineoplastic Agents > D020032 - Tyrphostins

   

Sporamin

(1S,2R,4S,5S)-9-butyl-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-9-ium bromide

C21H30BrNO4 (439.1358)


The major storage protein of sweet potato tubers Ipomoea batatas accounting for ca. 80\\% of total soluble protein. Possesses Trypsin inhibiting activity which may have a defense role against tuber damage. Sporamin is found in root vegetables.

   

Scopolamine butylbromide

(-)scopolamine N-butyl bromide

C21H30BrNO4 (439.1358)


   

Hyoscine_butylbromide

3-OXA-9-AZONIATRICYCLO(3.3.1.0 SUP(2,4))NONANE, 9-BUTYL-7-((2S)-3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9-METHYL-, BROMIDE (1:1),(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-

C21H30NO4+.Br- (439.1358)


Butylscopolamine bromide is an organic bromide salt of butylscopolamine. It is an antispasmodic drug which can relieve painful stomach cramps (including those linked with irritable bowel syndrome), bladder and menstrual cramps. It has a role as a muscarinic antagonist and an antispasmodic drug. It is an organic bromide salt and a quaternary ammonium salt. It contains a butylscopolamine. Butylscopolamine Bromide is an orally available bromide salt form of butylscopolamine, a quaternary ammonium derivative of the alkaloid scopolamine, with anticholinergic property. Upon oral administration, hyoscine butylbromide binds to and blocks muscarinic receptors located on postganglionic parasympathetic nerve endings and on smooth muscle cells. This blocks the activity of acetylcholine (Ach) and causes its antispasmodic effect in the gastrointestinal (GI), urinary, uterine, and biliary tracts. This agent may also facilitate radiologic visualization of the GI tract. Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

Althiomycin

Althiomycin

C16H17N5O6S2 (439.062)


A peptide antibiotic isolated from soil and enteric bacteria. It is a protein synthesis inhibitor which exhibits antibacterial activity against both Gram-positive and Gram-negative bacteria.

   

2-Methoxybenzyl glucosinolate

2-Methoxybenzyl glucosinolate

C15H21NO10S2 (439.0607)


   
   

Glucolimnathin

3-Methoxybenzyl glucosinolate

C15H21NO10S2 (439.0607)


   
   
   

N12-5(S)-N13-1(R)-L-digitoxosylarcyriaflavin A

N12-5(S)-N13-1(R)-L-digitoxosylarcyriaflavin A

C25H17N3O5 (439.1168)


   
   
   
   

Hyoscine_butylbromide

3-OXA-9-AZONIATRICYCLO(3.3.1.0 SUP(2,4))NONANE, 9-BUTYL-7-((2S)-3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9-METHYL-, BROMIDE (1:1),(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-

C21H30BrNO4 (439.1358)


Butylscopolamine bromide is an organic bromide salt of butylscopolamine. It is an antispasmodic drug which can relieve painful stomach cramps (including those linked with irritable bowel syndrome), bladder and menstrual cramps. It has a role as a muscarinic antagonist and an antispasmodic drug. It is an organic bromide salt and a quaternary ammonium salt. It contains a butylscopolamine. Butylscopolamine Bromide is an orally available bromide salt form of butylscopolamine, a quaternary ammonium derivative of the alkaloid scopolamine, with anticholinergic property. Upon oral administration, hyoscine butylbromide binds to and blocks muscarinic receptors located on postganglionic parasympathetic nerve endings and on smooth muscle cells. This blocks the activity of acetylcholine (Ach) and causes its antispasmodic effect in the gastrointestinal (GI), urinary, uterine, and biliary tracts. This agent may also facilitate radiologic visualization of the GI tract. Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract. C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

(2R)-2-Hydroxy-2-phenethylglucosinolate

(2R)-2-Hydroxy-2-phenethylglucosinolate

C15H21NO10S2 (439.0607)


Annotation level-1 Acquisition and generation of the data is financially supported in part by CREST/JST.

   

3-Methoxy-dictamnine-4-(2,3,4-trimethoxy)-benzoic acid

"NCGC00160277-01!3-Methoxy-dictamnine-4-(2,3,4-trimethoxy)-benzoic acid"

C23H21NO8 (439.1267)


   

Cys Cys Asn Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Cys Gln Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Cys Ser Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Cys Thr Asn

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Ser Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Ser Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Thr Cys Asn

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Cys Thr Asn Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Asn Cys Cys Thr

(2S,3R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C14H25N5O7S2 (439.1195)


   

Asn Cys Thr Cys

(2R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Asn Thr Cys Cys

(2R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Gln Cys Cys Ser

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C14H25N5O7S2 (439.1195)


   

Gln Cys Ser Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Gln Ser Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Ser Cys Cys Gln

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C14H25N5O7S2 (439.1195)


   

Ser Cys Gln Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Ser Gln Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Thr Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Thr Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Thr Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H25N5O7S2 (439.1195)


   

Hydroxytinidazole glucuronide

Hydroxytinidazole glucuronide

C14H21N3O11S (439.0897)


   

(2R)-2-Hydroxy-2-phenylethyl glucosinolate

{[(E)-(3-hydroxy-3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxy}sulfonic acid

C15H21NO10S2 (439.0607)


   

2-[[2-chloro-5-(trifluoromethyl)phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutyramide

2-[[2-chloro-5-(trifluoromethyl)phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutyramide

C18H13ClF3N5O3 (439.0659)


   

TERT-BUTYL 2-[1-(4-CHLOROPHENYL)-2-IODO-1-METHYLETHOXY]ETHYLCARBAMATE

TERT-BUTYL 2-[1-(4-CHLOROPHENYL)-2-IODO-1-METHYLETHOXY]ETHYLCARBAMATE

C16H23ClINO3 (439.0411)


   

Neodymium,tris(2,4-pentanedionato-kO2,kO4)-, (OC-6-11)-

Neodymium,tris(2,4-pentanedionato-kO2,kO4)-, (OC-6-11)-

C15H21NdO6-- (439.0415)


   

1-[p-(phenylsulphonyl)anilino]anthraquinone

1-[p-(phenylsulphonyl)anilino]anthraquinone

C26H17NO4S (439.0878)


   

C.I. Mordant black 11

2-hydroxy-1-(1-hydroxy-2-naphthylazo)-6-nitro-4-naphthalenesulfonic acid

C20H13N3O7S (439.0474)


D004396 - Coloring Agents

   

Tiplasinin

Tiplaxtinin

C24H16F3NO4 (439.1031)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent

   

5-bromo-1-tritylbenzotriazole

5-bromo-1-tritylbenzotriazole

C25H18BrN3 (439.0684)


   

2-(4-methoxy-3-nitrophenyl)-3-(4-methyl-3-nitrophenyl)sulfonyl-1,3-thiazolidine

2-(4-methoxy-3-nitrophenyl)-3-(4-methyl-3-nitrophenyl)sulfonyl-1,3-thiazolidine

C17H17N3O7S2 (439.0508)


   
   

propyl N-[4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophen-2-yl]sulfonylcarbamate

propyl N-[4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophen-2-yl]sulfonylcarbamate

C17H21N5O5S2 (439.0984)


   

propan-2-yl N-[4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophen-2-yl]sulfonylcarbamate

propan-2-yl N-[4-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophen-2-yl]sulfonylcarbamate

C17H21N5O5S2 (439.0984)


   

5-[4-(azetidin-3-yloxy)-3-methoxyphenyl]-2-(4-chlorophenyl)-[1,3]thiazolo[5,4-c]pyridin-4-one

5-[4-(azetidin-3-yloxy)-3-methoxyphenyl]-2-(4-chlorophenyl)-[1,3]thiazolo[5,4-c]pyridin-4-one

C22H18ClN3O3S (439.0757)


   
   

2-[[2-[(2-formamido-4-methylsulfanylbutanoyl)amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoic acid

2-[[2-[(2-formamido-4-methylsulfanylbutanoyl)amino]-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoic acid

C16H29N3O5S3 (439.1269)


   

(R)-2-(FMOC-AMINO)-3-(THIOPHEN-2-YLMETHYLSULFANYL)-PROPIONIC ACID

(R)-2-(FMOC-AMINO)-3-(THIOPHEN-2-YLMETHYLSULFANYL)-PROPIONIC ACID

C23H21NO4S2 (439.0912)


   

N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]-3,4,5-trimethoxybenzamide

N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]-3,4,5-trimethoxybenzamide

C19H22FN3O8 (439.1391)


   

2-(4-methoxyphenyl)-3-(4-methyl-3,5-dinitrophenyl)sulfonyl-1,3-thiazolidine

2-(4-methoxyphenyl)-3-(4-methyl-3,5-dinitrophenyl)sulfonyl-1,3-thiazolidine

C17H17N3O7S2 (439.0508)


   

Tie2 kinase inhibitor

4-(4-(6-methoxynaphthalen-2-yl)-2-(4-(methylsulfinyl)phenyl)-1H-imidazol-5-yl)pyridine

C26H21N3O2S (439.1354)


   

1-(4-isothiocyanatobenzyl)ethylenediamine-n,n,n,n-tetraacetic acid

1-(4-isothiocyanatobenzyl)ethylenediamine-n,n,n,n-tetraacetic acid

C18H21N3O8S (439.1049)


   

n-[3,5-bis(trifluoromethyl)benzenesulfonyl]-l-methionyl hydrazide

n-[3,5-bis(trifluoromethyl)benzenesulfonyl]-l-methionyl hydrazide

C13H15F6N3O3S2 (439.0459)


   
   

4-Methylumbelliferyl 2-Sulfamino-2-deoxy-α-D-glucopyranoside Sodium Salt

4-Methylumbelliferyl 2-Sulfamino-2-deoxy-α-D-glucopyranoside Sodium Salt

C16H18NNaO10S (439.0549)


   

lanthanum acetylacetonate

lanthanum acetylacetonate

C15H24LaO6 (439.0636)


   

1-Methyl-1-[4-(diphenylphosphino)benzyl]pyrrolidinium Bromide

1-Methyl-1-[4-(diphenylphosphino)benzyl]pyrrolidinium Bromide

C24H27BrNP (439.1064)


   

Boc-Tyr(2,6-Cl2-Bzl)-OH

Boc-Tyr(2,6-Cl2-Bzl)-OH

C21H23Cl2NO5 (439.0953)


   

BIA-3-335 free base

BIA-3-335 free base

C20H20F3N3O5 (439.1355)


   

8-Azabicyclo(3.2.1)octan-3-ol, 8-(bis(2-chlorophenyl)methyl)-3-(2-pyrimidinyl)-

8-Azabicyclo(3.2.1)octan-3-ol, 8-(bis(2-chlorophenyl)methyl)-3-(2-pyrimidinyl)-

C24H23Cl2N3O (439.1218)


   

Amibegron hydrochloride

Amibegron hydrochloride

C22H27Cl2NO4 (439.1317)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Amibegron hydrochloride is a selective β3-adrenoceptor agonist, with an EC50 of 3.5 nM for β-adrenoceptor in rat colon; Amibegron hydrochloride has anxiolytic and antidepressant activity.

   

N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide

N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide

C24H23Cl2N3O (439.1218)


   

Dimethyl 5-{3-[2-(4-methylbenzoyl)hydrazino]-2,5-dioxo-1-pyrrolidinyl}isophthalate

Dimethyl 5-{3-[2-(4-methylbenzoyl)hydrazino]-2,5-dioxo-1-pyrrolidinyl}isophthalate

C22H21N3O7 (439.1379)


   

N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C21H17N3O4S2 (439.066)


   

Folate(2-)

Folate(2-)

C19H17N7O6-2 (439.124)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(Z)-1-(glutathione-S-yl)-2-phenylacetohydroximate

(Z)-1-(glutathione-S-yl)-2-phenylacetohydroximate

C18H23N4O7S- (439.1287)


   

(gamma-glutamylcysteine-S-yl)-bimane

(gamma-glutamylcysteine-S-yl)-bimane

C18H23N4O7S- (439.1287)


   
   

1-S-[2-(3-methoxyphenyl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[2-(3-methoxyphenyl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose

C15H21NO10S2 (439.0607)


   

6a,7-Didehydro-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate

6a,7-Didehydro-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate

C21H20F3NO6 (439.1243)


A natural product found in Gnetum montanum.

   

1H-indole-4-carboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

1H-indole-4-carboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C25H17N3O3S (439.0991)


   

1-[(4-Fluorophenyl)methyl]-3-(2-furanylmethyl)-4-imino-6,6-dimethyl-5,8-dihydropyrano[2,3]thieno[2,4-b]pyrimidin-2-one

1-[(4-Fluorophenyl)methyl]-3-(2-furanylmethyl)-4-imino-6,6-dimethyl-5,8-dihydropyrano[2,3]thieno[2,4-b]pyrimidin-2-one

C23H22FN3O3S (439.1366)


   

2-(4-chlorophenoxy)-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]acetamide

2-(4-chlorophenoxy)-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]acetamide

C23H22ClN3O4 (439.1299)


   

2-[[3-[(4-fluorophenyl)methyl]-4-oxo-2-quinazolinyl]thio]-N-(thiophen-2-ylmethyl)acetamide

2-[[3-[(4-fluorophenyl)methyl]-4-oxo-2-quinazolinyl]thio]-N-(thiophen-2-ylmethyl)acetamide

C22H18FN3O2S2 (439.0824)


   

2-(1-Benzimidazolyl)acetic acid [2-[(9,10-dioxo-1-anthracenyl)amino]-2-oxoethyl] ester

2-(1-Benzimidazolyl)acetic acid [2-[(9,10-dioxo-1-anthracenyl)amino]-2-oxoethyl] ester

C25H17N3O5 (439.1168)


   

N-[4-[cyano-[3-(3-hydroxypropylamino)-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide

N-[4-[cyano-[3-(3-hydroxypropylamino)-2-quinoxalinyl]methyl]sulfonylphenyl]acetamide

C21H21N5O4S (439.1314)


   

[2-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] (E)-3-[4-(difluoromethoxy)-3-methoxyphenyl]prop-2-enoate

[2-(4-amino-1,3-dimethyl-2,6-dioxopyrimidin-5-yl)-2-oxoethyl] (E)-3-[4-(difluoromethoxy)-3-methoxyphenyl]prop-2-enoate

C19H19F2N3O7 (439.1191)


   

2-azaniumyl-5-[[3-[(Z)-C-benzyl-N-hydroxycarbonimidoyl]sulfanyl-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoate

2-azaniumyl-5-[[3-[(Z)-C-benzyl-N-hydroxycarbonimidoyl]sulfanyl-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoate

C18H23N4O7S- (439.1287)


   

(SP-4-3)-[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O]{1-[(2R)-pyrrolidin-2-yl-kappaN]methanamine-kappaN}platinum

(SP-4-3)-[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O]{1-[(2R)-pyrrolidin-2-yl-kappaN]methanamine-kappaN}platinum

C11H20N2O4Pt+2 (439.1071)


   

(4-Bromo-5-methyl-3-isoxazolyl)-[4-(diphenylmethyl)-1-piperazinyl]methanone

(4-Bromo-5-methyl-3-isoxazolyl)-[4-(diphenylmethyl)-1-piperazinyl]methanone

C22H22BrN3O2 (439.0895)


   

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide

C19H25N3O5S2 (439.1236)


   

N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[4-methoxy-3-(sulfooxy)phenyl]propanimidic acid

N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[4-methoxy-3-(sulfooxy)phenyl]propanimidic acid

C20H25NO8S (439.1301)


   

[4-[2-[3-(3,4-Dimethoxyphenyl)propanoylamino]ethyl]-2-methoxyphenyl] hydrogen sulate

[4-[2-[3-(3,4-Dimethoxyphenyl)propanoylamino]ethyl]-2-methoxyphenyl] hydrogen sulate

C20H25NO8S (439.1301)


   

sulfo 1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methylpiperazin-1-yl]-4-oxoquinoline-3-carboxylate

sulfo 1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methylpiperazin-1-yl]-4-oxoquinoline-3-carboxylate

C19H22FN3O6S (439.1213)


   

1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methyl-4-sulfopiperazin-1-yl]-4-oxoquinoline-3-carboxylic acid

1-cyclopropyl-6-fluoro-5-methyl-7-[(3S)-3-methyl-4-sulfopiperazin-1-yl]-4-oxoquinoline-3-carboxylic acid

C19H22FN3O6S (439.1213)


   

4,8-Dimethoxyfuro[2,3-b]quinolin-7-yl 3,4,5-trimethoxybenzoate

4,8-Dimethoxyfuro[2,3-b]quinolin-7-yl 3,4,5-trimethoxybenzoate

C23H21NO8 (439.1267)


   
   

N-Desmethyl-o-O-sulfate rosiglitazone

N-Desmethyl-o-O-sulfate rosiglitazone

C17H17N3O7S2 (439.0508)


   

Folate(2-)

Folate(2-)

C19H17N7O6 (439.124)


The dicarboxylic acid dianion formed from folic acid by loss of a proton from each of the two carboxy groups in the glutamic acid moiety.

   
   

Zamaporvint

Zamaporvint

C21H16F3N7O (439.1368)


Zamaporvint (RXC004) is an orally active and selective inhibitor of Wnt. Zamaporvint targete membrane-bound o-acyltransferase Porcupine and inhibited Wnt ligand palmitoylation, secretion, and pathway activation. Zamaporvint displays a favorable pharmacokinetic profile and shows potent antiproliferative effects in Wnt ligand-dependent colorectal and pancreatic cell lines. Zamaporvint possesses multiple antitumor mechanisms and can be used in cancer research[1].

   

methyl 4-[hydroxy(methoxy)methyl]furan-2-carboxylate; utahmycin a

methyl 4-[hydroxy(methoxy)methyl]furan-2-carboxylate; utahmycin a

C23H21NO8 (439.1267)


   

[(e)-[(3r)-3-hydroxy-3-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene]amino]oxysulfonic acid

[(e)-[(3r)-3-hydroxy-3-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene]amino]oxysulfonic acid

C15H21NO10S2 (439.0607)


   

[(3-hydroxy-3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(3-hydroxy-3-phenyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C15H21NO10S2 (439.0607)


   

[(e)-[2-(3-methoxyphenyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

[(e)-[2-(3-methoxyphenyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

C15H21NO10S2 (439.0607)


   

[(z)-[2-(3-methoxyphenyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

[(z)-[2-(3-methoxyphenyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

C15H21NO10S2 (439.0607)


   

methyl (1r,3r,4r,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

methyl (1r,3r,4r,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

C17H21N5O9 (439.1339)


   

{[2-(3-methoxyphenyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino}oxysulfonic acid

{[2-(3-methoxyphenyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino}oxysulfonic acid

C15H21NO10S2 (439.0607)


   

(2r)-3-({[1-hydroxy-7-(hydroxymethyl)-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl]methyl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-({[1-hydroxy-7-(hydroxymethyl)-3,6-dimethoxy-5,8-dioxonaphthalen-2-yl]methyl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid

C19H21NO9S (439.0937)


   

(1s,17s,20z,24r,26r)-4,24-dihydroxy-26-(1-hydroxyethyl)-25-oxa-16-azahexacyclo[15.7.2.0¹,²⁶.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]hexacosa-2,4,7,9,11,14,20-heptaen-18,22-diyne-6,13-dione

(1s,17s,20z,24r,26r)-4,24-dihydroxy-26-(1-hydroxyethyl)-25-oxa-16-azahexacyclo[15.7.2.0¹,²⁶.0²,¹⁵.0⁵,¹⁴.0⁷,¹²]hexacosa-2,4,7,9,11,14,20-heptaen-18,22-diyne-6,13-dione

C26H17NO6 (439.1056)


   
   

[(e)-[(3s)-3-hydroxy-3-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene]amino]oxysulfonic acid

[(e)-[(3s)-3-hydroxy-3-phenyl-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene]amino]oxysulfonic acid

C15H21NO10S2 (439.0607)


   

(2z)-n-{2-hydroxy-1-[4-(4-methoxy-2-oxo-5h-pyrrole-1-carbonyl)-4,5-dihydro-1,3-thiazol-2-yl]ethyl}-2-(nitrosomethylidene)-3h-1,3-thiazole-4-carboximidic acid

(2z)-n-{2-hydroxy-1-[4-(4-methoxy-2-oxo-5h-pyrrole-1-carbonyl)-4,5-dihydro-1,3-thiazol-2-yl]ethyl}-2-(nitrosomethylidene)-3h-1,3-thiazole-4-carboximidic acid

C16H17N5O6S2 (439.062)


   

n-{2-hydroxy-1-[4-(4-methoxy-2-oxo-5h-pyrrole-1-carbonyl)-4,5-dihydro-1,3-thiazol-2-yl]ethyl}-2-[(z)-(hydroxyimino)methyl]-1,3-thiazole-4-carboximidic acid

n-{2-hydroxy-1-[4-(4-methoxy-2-oxo-5h-pyrrole-1-carbonyl)-4,5-dihydro-1,3-thiazol-2-yl]ethyl}-2-[(z)-(hydroxyimino)methyl]-1,3-thiazole-4-carboximidic acid

C16H17N5O6S2 (439.062)


   

[(e)-[(3s)-3-hydroxy-3-phenyl-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene]amino]oxysulfonic acid

[(e)-[(3s)-3-hydroxy-3-phenyl-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene]amino]oxysulfonic acid

C15H21NO10S2 (439.0607)


   

{[2-(3-methoxyphenyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino}oxysulfonic acid

{[2-(3-methoxyphenyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino}oxysulfonic acid

C15H21NO10S2 (439.0607)


   

n-{2-hydroxy-1-[4-(4-methoxy-2-oxo-5h-pyrrole-1-carbonyl)-4,5-dihydro-1,3-thiazol-2-yl]ethyl}-2-(nitrosomethylidene)-3h-1,3-thiazole-4-carboximidic acid

n-{2-hydroxy-1-[4-(4-methoxy-2-oxo-5h-pyrrole-1-carbonyl)-4,5-dihydro-1,3-thiazol-2-yl]ethyl}-2-(nitrosomethylidene)-3h-1,3-thiazole-4-carboximidic acid

C16H17N5O6S2 (439.062)


   

[(z)-[2-(3-methoxyphenyl)-1-{[(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

[(z)-[2-(3-methoxyphenyl)-1-{[(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}ethylidene]amino]oxysulfonic acid

C15H21NO10S2 (439.0607)


   

methyl (1r,3s,4s,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

methyl (1r,3s,4s,5r,7r,9r,11s,12s,13s)-5-(6-aminopurin-9-yl)-1,4,12,13-tetrahydroxy-2,6,10-trioxatricyclo[7.4.0.0³,⁷]tridecane-11-carboxylate

C17H21N5O9 (439.1339)